| Covasim: an agent-based model of COVID-19 dynamics and interventions CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, K Rosenfeld, GR Hart, ... PLOS Computational Biology 17 (7), e1009149, 2021 | 572 | 2021 |
| Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study A Palmer, N Scott, P Dietze, P Higgs Harm reduction journal 17, 1-6, 2020 | 70 | 2020 |
| Modelling the impact of relaxing COVID‐19 control measures during a period of low viral transmission N Scott, A Palmer, D Delport, R Abeysuriya, RM Stuart, CC Kerr, D Mistry, ... Medical Journal of Australia 214 (2), 79-83, 2021 | 54 | 2021 |
| Staying hepatitis C negative: a systematic review and meta‐analysis of cure and reinfection in people who inject drugs NH Latham, JS Doyle, AY Palmer, JW Vanhommerig, P Agius, ... Liver International 39 (12), 2244-2260, 2019 | 50 | 2019 |
| Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study N Scott, A Palmer, C Morgan, O Lesi, CW Spearman, M Sonderup, ... The lancet global health 6 (6), e659-e667, 2018 | 47 | 2018 |
| A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment AY Palmer, AJ Wade, B Draper, J Howell, JS Doyle, D Petrie, ... International Journal of Drug Policy 76, 102633, 2020 | 25 | 2020 |
| “Just not all ice users do that”: investigating perceptions and potential harms of Australia’s Ice Destroys Lives campaign in two studies CH Douglass, EC Early, CJC Wright, A Palmer, P Higgs, B Quinn, ... Harm reduction journal 14, 1-8, 2017 | 18 | 2017 |
| A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison A Palmer, T Papaluca, M Stoové, R Winter, A Pedrana, M Hellard, ... International Journal of Drug Policy 94, 103203, 2021 | 13 | 2021 |
| Prevalence and correlates of simultaneous, multiple substance injection (co‐injection) among people who inject drugs in Melbourne, Australia A Palmer, P Higgs, N Scott, P Agius, L Maher, P Dietze Addiction 116 (4), 876-888, 2021 | 13 | 2021 |
| Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study N Scott, MA Palmer, MT Tidhar, M Stoove, R Sacks-Davis, A Pedrana, ... The Lancet Regional Health–Western Pacific 18, 2022 | 8 | 2022 |
| Covasim: an agent-based model of COVID-19 dynamics and interventions. MedRxiv, 2020.05. 10.20097469 CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, G Hart, K Rosenfeld, ... | 7 | 2020 |
| Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts F Houdroge, A Palmer, D Delport, T Walsh, SL Kelly, SW Hainsworth, ... Scientific Reports 13 (1), 1398, 2023 | 3 | 2023 |
| Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale‐up of direct‐acting antiviral treatment AY Palmer, A Wilkinson, C Aitken, P Dietze, GJ Dore, L Maher, ... Journal of Gastroenterology and Hepatology 36 (8), 2270-2274, 2021 | 3 | 2021 |
| A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community‐based testing campaign AY Palmer, K Chan, J Gold, C Layton, I Elsum, M Hellard, M Stoove, ... Journal of Viral Hepatitis 28 (11), 1624-1634, 2021 | 2 | 2021 |
| Cost optimisation analysis of the expanded programme for immunisation: balancing equity and coverage in Pakistan F Houdroge, H Yunus, D Delport, E Stearns, A Palmer, A Naim, A Kashif, ... BMJ Global Health 7 (10), e009000, 2022 | 1 | 2022 |
| Covasim: an agent-based model of COVID-19 dynamics and interventions (preprint) CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, G Hart, K Rosenfeld, ... | 1 | 2020 |
| Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar TM Win, BL Draper, A Palmer, H Htay, YY Sein, S Shilton, KP Kyi, ... JGH Open 7 (11), 755-764, 2023 | | 2023 |
| Predicting the unpredictable: how dynamic COVID-19 policies and restrictions challenge model forecasts F Houdroge, A Palmer, D Delport, T Walsh, SL Kelly, SW Hainsworth, ... medRxiv, 2021.09. 30.21264273, 2021 | | 2021 |
| Predicting the unpredictable: how dynamic COVID-19 policies and restrictions challenge model forecasts (preprint) F Houdroge, A Palmer, D Delport, T Walsh, SL Kelly, SW Hainsworth, ... | | 2021 |
| Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting (preprint) N Scott, A Palmer, D Delport, R Abeysuriya, R Stuart, CC Kerr, D Mistry, ... | | 2020 |
